Combination Lipid Therapy in Type 2 Diabetes

被引：0
作者：
Michael Clearfield
机构：
[1] Touro University College of Osteopathic Medicine,
来源：
Current Atherosclerosis Reports | 2011年 / 13卷 / 1期
关键词：
Statin; Simvastatin; Statin Therapy; Fenofibrate; Gemfibrozil;
D O I：
10.1007/s11883-010-0139-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 3
页数：2
相关论文
共 50 条
  • [41] Dyslipidemia in type 2 diabetes mellitus
    Gadi R.
    Samaha F.F.
    Current Diabetes Reports, 2007, 7 (3) : 228 - 234
  • [42] Treatment of lipids and type 2 diabetes
    Hermayer K.L.
    Current Cardiology Reports, 2004, 6 (6) : 443 - 450
  • [43] Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia
    Lee, Sang-Hak
    Cho, Kyoung-Im
    Kim, Jang-Young
    Ahn, Young Keun
    Rha, Seung-Woon
    Kim, Yong-Jin
    Choi, Yun-Seok
    Choi, Si Wan
    Jeon, Dong Woon
    Min, Pil-Ki
    Choi, Dong-Ju
    Baek, Sang Hong
    Kim, Kwon Sam
    Byun, Young Sup
    Jang, Yangsoo
    ATHEROSCLEROSIS, 2012, 221 (01) : 169 - 175
  • [44] Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter, Rajesh
    Reilly, Elizabeth
    Anthony, Sony
    CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (06) : 554 - 555
  • [45] Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis
    Rodriguez-Gutierrez, Rene
    Garcia-Leal, Mariana
    Raygoza-Cortez, Karina
    Flores-Rodriguez, Andrea
    Moreno-Alvarado, Marcela
    Heredia-Martinez, E. Maximiliano
    Vazquez-Baquerizo, Briana
    Guerra-Espiricueta, Raul
    Munoz-Silva, Valeria
    Gonzalez-Gonzalez, Jose Gerardo
    ENDOCRINE, 2023, 81 (02) : 231 - 245
  • [46] Beyond low-density lipoprotein: Addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome
    Nesto R.W.
    American Journal of Cardiovascular Drugs, 2005, 5 (6) : 379 - 387
  • [47] Optimisation of quality indicators for lipid-lowering treatment of type 2 diabetes mellitus
    Madsen, Michael Moesmann
    Kaersvang, Lone
    Hansen, Anders Wurgler
    Flink, Morten
    Nielsen, Henning K.
    Hansen, Klaus Wurgler
    DANISH MEDICAL JOURNAL, 2018, 65 (09):
  • [48] Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes
    Shigematsu, Erina
    Yamakawa, Tadashi
    Taguri, Masataka
    Morita, Satoshi
    Tokui, Mikiya
    Miyamoto, Kazunori
    Funae, Osamu
    Takatuka, Yoji
    Kadonosono, Kazuaki
    Shigematsu, Hiroshi
    Terauchi, Yasuo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (09) : 846 - 853
  • [49] Determinants of inertia with lipid-lowering treatment in patients with type 2 diabetes mellitus
    Garcia Diaz, Eduardo
    Ramirez Medina, Davinia
    Morera Porras, Oscar Mauricio
    Cabrera Mateos, Jose Luis
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (04): : 223 - 231
  • [50] Rosuvastatin decreases testosterone levels but not sexual function in men with type 2 diabetes
    Hsieh, Ching Jung
    Huang, Bin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : 81 - 88
12345